Conmed (CNMD) Tops Q1 EPS by 8c; Hikes FY22 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
CONMED Corporation Announces First Quarter 2022 Financial Results
May 4, 2022 4:05 PM EDTLARGO, Fla.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2022.
First Quarter 2022 Highlights
Sales of $242.3 million increased 4.1% year over year as reported and 4.3% in constant currency. Domestic revenue increased 5.9% year over year. International revenue increased 2.2% year over year as reported and 2.6% in constant currency. Diluted net earnings per share (GAAP) were $0.47, an increase of 51.6% over the first quarter of 2021. Adjusted diluted net earnings per share(1) were $0.70, an... More